Related Experiment Videos
Plasma exchange in myasthenia gravis: clinical effect
Acta Neurologica Scandinavica
|November 1, 1985
Summary
Plasma exchange effectively treated myasthenia gravis in 17 patients, with most experiencing symptom improvement within days. This study highlights plasma exchange as a safe and beneficial therapeutic option for managing myasthenia gravis.
Area of Science:
- Neurology
- Immunology
Background:
- Myasthenia gravis is a chronic autoimmune neuromuscular disease.
- Current treatments for myasthenia gravis can have significant side effects.
Purpose of the Study:
- To evaluate the efficacy and safety of plasma exchange in patients with myasthenia gravis.
Main Methods:
- Seventeen patients diagnosed with myasthenia gravis underwent plasma exchange therapy.
- Patient outcomes were assessed based on clinical improvement and changes in the Osserman classification.
Main Results:
- Plasma exchange was well-tolerated, with no serious complications reported.
- Symptomatic improvement was typically observed by the second or third day of treatment.
- Out of 12 patients who received 31 plasma exchange courses, 6 achieved long-standing remissions, 3 showed moderate improvement, and 2 did not respond.
Conclusions:
- Plasma exchange is a safe and effective treatment for myasthenia gravis.
- The therapy can induce significant clinical improvement and long-term remission in a substantial proportion of patients.